Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Hepatol. Sep 27, 2014; 6(9): 626-631
Published online Sep 27, 2014. doi: 10.4254/wjh.v6.i9.626
Table 1 Studies comparing living - donor liver transplantation and deceased - donor liver transplantation for hepatocellular carcinoma
Ref.CountryYearStudy periodType of LTCase numberRecurrence - free survival
P% Recur-rence ratePCriteria used% Outside MilanDifferencein tumorcharact-eristicsMedian follow-up period (mo)
1-yr3-yr5-yr
Impaired results in LDLT
Park et al[10]South Korea20141999-2010LDLT16689810.045190.045UCSFNAnone35
DDLT5096946
Vakili et al[13]United States20091999-2007LDLT28290.05UNOS25none41
DDLT6512
Kulik et al[12]United States20121998-2010LDLT1008066560.05380.0004UNOS59More aggressive in LDLT60
Multi-centerDDLT979081731130
Lo et al[14]Hong Kong20071995-2004LDLT439371710.029290.029UCSF26More aggressive in LDLT33
DDLT17100100100029
Comparable results
Sandhu et al[15]Canada20131996-2009LDLT58887570NS17NSToronto criteria28none38
DDLT287867570153231
Bhangui et al[16]France20112000-2009LDLT361008988NS13NSUCSF27none58
DDLT120938986132150
Li et al[36]China20102005-2009LDLT387142NS50NSUCSF79none25
DDLT10176415568
Di Sandro et al[35]Italy20092000-2007LDLT259696NS4NSMilan20noneNA
DDLT15491891131
Sotiropoulos et al[20]Germany20071998-2006LDLT458875NS12NSUCSF44noneNA
DDLT558114
Hwang et al[8]South Korea20051992-2002LDLT2378380NS18NS27none26
Multi-centerDDLT758882162945
Gondolesi et al[17]United States20041988-2002LDLT368274NS19NSUNOS53none15
DDLT165908319